CIK 0001754068 · Non-accelerated filer<br>Smaller reporting company
Kalaris Therapeutics, Inc.
Sign in to watch- Ticker
- KLRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831971007
- Phone
- 650-249-2727
- Business address
- 400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Allovir, Inc., ViraCyte, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-19 | Hagen Brett R Chief Accounting Officer | Sale | −544 | $0.76 | $413 | 71,981 |
| 2024-08-19 | Sinha Vikas See Remarks | Sale | −3,159 | $0.76 | $2K | 1,153,584 |
| 2024-08-19 | Brainard Diana Chief Executive Officer | Sale | −3,091 | $0.76 | $2K | 759,313 |
| 2024-08-05 | Sinha Vikas See Remarks | Sale | −5,251 | $0.73 | $4K | 1,156,743 |
| 2024-08-05 | Miller Edward General Counsel | Sale | −2,323 | $0.73 | $2K | 216,403 |
| 2024-08-05 | Brainard Diana Chief Executive Officer | Sale | −10,847 | $0.73 | $8K | 762,404 |
| 2024-08-05 | Hagen Brett R Chief Accounting Officer | Sale | −1,692 | $0.73 | $1K | 72,525 |
| 2024-07-22 | Hagen Brett R Chief Accounting Officer | Sale | −481 | $0.74 | $356 | 74,217 |
| 2024-07-22 | Sinha Vikas See Remarks | Sale | −1,858 | $0.74 | $1K | 1,161,994 |
| 2024-07-22 | Miller Edward General Counsel | Sale | −757 | $0.74 | $560 | 218,726 |
| 2024-07-19 | Hagen Brett R Chief Accounting Officer | Sale | −479 | $0.75 | $359 | 74,698 |
| 2024-07-19 | Brainard Diana Chief Executive Officer | Sale | −9,731 | $0.75 | $7K | 773,251 |
| 2024-07-19 | Sinha Vikas See Remarks | Sale | −1,542 | $0.75 | $1K | 1,163,852 |
| 2024-07-19 | Miller Edward General Counsel | Sale | −634 | $0.75 | $476 | 219,483 |
| 2024-07-02 | Miller Edward General Counsel | Sale | −379 | $0.72 | $273 | 220,117 |
| 2024-07-02 | Sinha Vikas See Remarks | Sale | −939 | $0.72 | $676 | 1,165,394 |
| 2024-07-02 | Hagen Brett R Chief Accounting Officer | Sale | −304 | $0.72 | $219 | 75,177 |
| 2024-07-02 | Brainard Diana Chief Executive Officer | Sale | −1,489 | $0.72 | $1K | 782,982 |
| 2024-06-06 | Jovan-Embiricos Morana Director | Grant or award | +35,000 | 100,197 | ||
| 2024-06-06 | Adams Derek N. Director | Grant or award | +35,000 | 70,000 |
Page 5 of 7 · 122 trades